<Disease><Name>GLUTARIC ACIDURIA I</Name><Synonym>ACIDEMIA, GLUTARIC ACIDEMIA I</Synonym><OMIM><Number>231670</Number><URL>http://omim.org/entry/231670</URL></OMIM><Orphanet><Number>25</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=25</URL></Orphanet><Protein><Number>Glutaryl-CoA dehydrogenase, mitochondrial</Number><URL>http://www.uniprot.org/uniprot/Q92947</URL></Protein><ExPASy><Number>1.3.8.6</Number><URL>http://enzyme.expasy.org/EC/1.3.8.6</URL></ExPASy><Gene>19p13.13</Gene><ICD>E72.3</ICD><Summary>rare (1:110000) ;autosomal recessiv;high- or ;low;-excreter variants [Al-Dirbashy OY 2011];Presentation and progression of disease are variable ranging from asymptomatic carrier state to catastrophic encephalopathy [Fraidakis MJ 2015];subdural hemorrhage may be a life-threatening complication after minor head ;trauma [Zielonka M et al. 2015]</Summary><Symptoms><symtomp><id>3424</id><symptom>abnormal movement</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2363</id><symptom>basal ganglia, changes, lesions, calcifications (MRI, CT)</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2130</id><symptom>bleeding tendencies, hemorrhages / bleeding tendencies, hemorrhage</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2117</id><symptom>CT, brain, abnormalities [-] / CT, kraniell, abnormal </symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2457</id><symptom>dyskinesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>4107</id><symptom>Encephalopathic crisis, acute</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2105</id><symptom>encephalopathy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1969</id><symptom>extrapyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2095</id><symptom>failure to thrive</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp><symtomp><id>1979</id><symptom>feeding difficulties, poor feeding</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1713</id><symptom>fever, severe or recurrent</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2456</id><symptom>grimacing</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1925</id><symptom>headache (severe, recurrent or occipital, migraine)</symptom><category>GENERAL TOPICS | HEAD</category></symtomp><symtomp><id>1994</id><symptom>hepatomegaly (large liver)</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3455</id><symptom>intracranial hemorrhage, hematoma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3198</id><symptom>ketosis, ketoacidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3381</id><symptom>learning disability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1887</id><symptom>macrocephaly (large calvaria, &gt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>2065</id><symptom>metabolic acidosis</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2418</id><symptom>myelination, incomplete, hypomyelination</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3168</id><symptom>nephrotic syndrome / neprhrotic syndrome</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2298</id><symptom>opisthotonus</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2089</id><symptom>Organic acids, urine</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3311</id><symptom>Parkinsonism</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3903</id><symptom>periventricular white matter changes</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2273</id><symptom>pneumonia</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1919</id><symptom>progressive neurologic defect</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4080</id><symptom>subdural effusions</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3456</id><symptom>subdural haematoma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2142</id><symptom>swallowing difficulties</symptom><category>GASTROINTESTINAL SYSTEM | GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1935</id><symptom>vertigo, dizziness</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1589</id><name>Acylcarnitine (C2)</name><specimen>urine</specimen><value>increased</value><min>0.60</min><max>7.50</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1639</id><name>L-Carnitine</name><specimen>urine</specimen><value>increased</value><min>0.70</min><max>16.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>2072</id><name>3-Hydroxyglutaric acid</name><specimen>plasma</specimen><value>increased</value><min>0.20</min><max>1.36</max><unit>&#956;mol/l</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1720</id><name>3-Hydroxyglutaric acid</name><specimen>urine</specimen><value>increased</value><min>41.00</min><max>44.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1730</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>97.00</min><max>100.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment /></metabolite><metabolite><id>1811</id><name>Glutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>67.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>2092</id><name>Glutarylcarnitine (C5DC)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.10</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>GCMS</method><comment>&lt; cut off</comment></metabolite><metabolite><id>348</id><name>3-Hydroxybutyric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>280.00</max><unit>&#956;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>349</id><name>3-Hydroxybutyric acid</name><specimen>plasma</specimen><value>increased</value><min>22.00</min><max>700.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>510</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.50</min><max>9.80</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>512</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.10</min><max>5.80</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>513</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>1.30</min><max>6.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>713</id><name>3-Hydroxybutyric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>20.00</min><max>60.00</max><unit>&#956;mol/l</unit><age /><method /><comment /></metabolite><metabolite><id>237</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.10</min><max>1.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>240</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.10</min><max>0.90</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>243</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.00</min><max>0.30</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>238</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.50</min><max>2.30</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>241</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.80</min><max>2.60</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>244</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.10</min><max>0.80</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>239</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>1.10</min><max>2.80</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>242</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>2.50</min><max>5.20</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>245</id><name>3-Hydroxybutyric acid</name><specimen>blood</specimen><value>increased</value><min>0.70</min><max>1.70</max><unit>mmol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>511</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>1.00</min><max>6.00</max><unit>mmol/mol creatinine</unit><age>infancy</age><method /><comment /></metabolite><metabolite><id>526</id><name>3-Hydroxybutyric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>91</id><name>3-Hydroxyglutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>7.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1354</id><name>3-Hydroxyglutaric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.00</min><max>0.19</max><unit>&#956;mol/l</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1212</id><name>Acylcarnitine (C2)</name><specimen>blood</specimen><value>increased</value><min>12.40</min><max>50.70</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1216</id><name>Acylcarnitine (C2)</name><specimen>serum</specimen><value>increased</value><min>21.10</min><max>86.20</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>270</id><name>L-Carnitine</name><specimen>urine</specimen><value>increased</value><min>8.00</min><max>21.00</max><unit>mmol/mol creatinine</unit><age>child</age><method /><comment /></metabolite><metabolite><id>272</id><name>L-Carnitine</name><specimen>urine</specimen><value>increased</value><min>0.60</min><max>15.40</max><unit>mmol/mol creatinine</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1214</id><name>L-Carnitine</name><specimen>blood</specimen><value>increased</value><min>6.83</min><max>43.45</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1215</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>11.61</min><max>73.87</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>59</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>23.00</min><max>60.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>268</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>35.00</min><max>55.00</max><unit>&#181;mol/l</unit><age>adult</age><method /><comment /></metabolite><metabolite><id>1090</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>20.00</min><max>40.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1163</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>15.00</min><max>40.00</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1213</id><name>L-Carnitine</name><specimen>blood</specimen><value>decreased</value><min>10.00</min><max>44.00</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1141</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>13.00</min><max>23.00</max><unit>&#181;mol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1142</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>11.50</min><max>18.00</max><unit>&#181;mol/l</unit><age>1-7 years</age><method /><comment /></metabolite><metabolite><id>1143</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>18.00</min><max>30.00</max><unit>&#181;mol/l</unit><age>7-15 years</age><method /><comment /></metabolite><metabolite><id>267</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>40.00</min><max>60.00</max><unit>&#181;mol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1089</id><name>L-Carnitine</name><specimen>plasma</specimen><value>decreased</value><min>9.00</min><max>23.00</max><unit>&#181;mol/l</unit><age>premature</age><method /><comment /></metabolite><metabolite><id>92</id><name>E-Glutaconic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>2.00</max><unit>mmol/mol creatinine</unit><age>childhood</age><method /><comment /></metabolite><metabolite><id>1344</id><name>E-Glutaconic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>11.00</max><unit>mmol/mol creatinine</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1619</id><name>E-Glutaconic acid</name><specimen>urine</specimen><value>normal/inc</value><min>1.20</min><max>3.10</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1807</id><name>E-Glutaconic acid</name><specimen>urine</specimen><value>normal/inc</value><min>0.00</min><max>130.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>56</id><name>Glutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.70</min><max>3.60</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>551</id><name>Glutaric acid</name><specimen>urine</specimen><value>increased</value><min>3.00</min><max>19.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>552</id><name>Glutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>15.00</max><unit>mmol/mol creatinine</unit><age>Infancy</age><method /><comment /></metabolite><metabolite><id>553</id><name>Glutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>5.00</max><unit>mmol/mol creatinine</unit><age>childhood 6-12y</age><method /><comment /></metabolite><metabolite><id>554</id><name>Glutaric acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>9.00</max><unit>mmol/mol creatinine</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>284</id><name>Glutaric acid</name><specimen>plasma</specimen><value>increased</value><min>0.50</min><max>2.90</max><unit>&#956;mol/l</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>360</id><name>Glutaric acid</name><specimen>cerebrospinal fluid</specimen><value>increased</value><min>0.18</min><max>0.63</max><unit>&#956;mol/l</unit><age>ALL</age><method>GCMS</method><comment /></metabolite><metabolite><id>1235</id><name>Glutarylcarnitine (C5DC)</name><specimen>blood</specimen><value>increased</value><min>0.00</min><max>0.09</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>1236</id><name>Glutarylcarnitine (C5DC)</name><specimen>serum</specimen><value>increased</value><min>0.01</min><max>0.15</max><unit>&#181;mol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>475</id><name>Ketone bodies (urine)</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>negative</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>2025</id><name>L-Carnitine</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>0.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>Bruker 2018</comment></metabolite><metabolite><id>416</id><name>Transaminases (ASAT/ALAT)</name><specimen>serum</specimen><value>normal/inc</value><min>10.00</min><max>30.00</max><unit>U/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7421</id><title>Elevated levels of BDNF and cathepsin-d as possible peripheral markers of neurodegeneration in plasma of patients with glutaric</title><author>Guerreiro G,</author><journal>Int J Dev Neurosci</journal><year>2020</year><book /><volume>80</volume><number>1</number><pages>42-49</pages><co_aut>et al.</co_aut></literature><literature><id>6472</id><title>Patterns, evolution, and severity of striatal injury in insidious- vs acute-onset glutaric aciduria type 1</title><author>Boy N,</author><journal>J Inherit Metab Dis</journal><year>2019</year><book /><volume>42</volume><number>1</number><pages>117-127</pages><co_aut>et al.</co_aut></literature><literature><id>6473</id><title>Dyskinesia in a Child: A Concern for a Rare Neuro-Metabolic Disorder</title><author>Hafeez A,</author><journal>J Coll Physicians Surg Pak</journal><year>2019</year><book /><volume>29</volume><number>1</number><pages>84-86</pages><co_aut>et al.</co_aut></literature><literature><id>6675</id><title>Mild phenotype of glutaric aciduria type 1 in polish patients - novel data from a group of 13 cases</title><author>Pokora P,</author><journal>Metab Brain Dis</journal><year>2019</year><book /><volume>34</volume><number>2</number><pages>641-649</pages><co_aut>et al.</co_aut></literature><literature><id>7267</id><title>Formation of 3-hydroxyglutaric acid in glutaric aciduria type I: in vitro participation of medium chain acyl-CoA dehydrogenase</title><author>Peters V,</author><journal>JIMD Rep</journal><year>2019</year><book /><volume>47</volume><number>1</number><pages>30-34</pages><co_aut>et al.</co_aut></literature><literature><id>7418</id><title>Glutaric Acidemia Type 1</title><author>Larson A,</author><journal>GeneReviews&#174; [Internet]</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Goodman S</co_aut></literature><literature><id>7419</id><title>Clinical, biochemical, neuroradiological and molecular characterization of Egyptian patients with glutaric acidemia type 1</title><author>Zayed H,</author><journal>Metab Brain Dis</journal><year>2019</year><book /><volume>34</volume><number>4</number><pages>1231-1241</pages><co_aut>et al.</co_aut></literature><literature><id>7420</id><title>An explanation for metabolite excretion in high- and low-excretor patients with glutaric acidemia type 1</title><author>Goodman SI,</author><journal>Mol Genet Metab</journal><year>2019</year><book /><volume>127</volume><number>4</number><pages>325-326</pages><co_aut>Woontner M</co_aut></literature><literature><id>7422</id><title>Riga Fede Disease with Glutaric Aciduria Type 1</title><author>Sivamurukan P,</author><journal>Indian J Pediatr</journal><year>2019</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Chandrasekaran V, Biswal N</co_aut></literature><literature><id>7423</id><title>What are the information needs of parents caring for a child with Glutaric aciduria type 1?</title><author>Piercy H,</author><journal>BMC Pediatr</journal><year>2019</year><book /><volume>19</volume><number>1</number><pages>349</pages><co_aut>et al.</co_aut></literature><literature><id>6102</id><title>Favourable outcome in a child with symptomatic diagnosis of Glutaric aciduria type 1 despite vertical HIV infection and minor h</title><author>Thomas A,</author><journal>Metab Brain Dis</journal><year>2018</year><book /><volume>33</volume><number>2</number><pages>537-544</pages><co_aut>et al.</co_aut></literature><literature><id>6105</id><title>Prenatal diagnosis of fetal glutaric aciduria type 1 with rare compound heterozygous mutations in GCDH gene</title><author>Peng HH,</author><journal>Taiwan J Obstet Gynecol</journal><year>2018</year><book /><volume>57</volume><number>1</number><pages>137-140</pages><co_aut>Shaw SW, Huang KG</co_aut></literature><literature><id>6106</id><title>Newborn screening: A disease-changing intervention for glutaric aciduria type 1</title><author>Boy N,</author><journal>Ann Neurol</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6107</id><title>Patterns, evolution, and severity of striatal injury in insidious- versus acute-onset glutaric aciduria type 1</title><author>Boy N,</author><journal>J Inherit Metab Dis</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6352</id><title>Early neonatal Glutaric aciduria type I hidden by perinatal asphyxia: a case report</title><author>Biasucci G,</author><journal>Ital J Pediatr</journal><year>2018</year><book /><volume>44</volume><number>1</number><pages>8</pages><co_aut>et al.</co_aut></literature><literature><id>6474</id><title>Mild phenotype of glutaric aciduria type 1 in polish patients - novel data from a group of 13 cases</title><author>Pokora P,</author><journal>Metab Brain Dis</journal><year>2018</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6477</id><title>A Case of Mistaken Identity: Glutaric Aciduria Type I Masquerading as Postmeningitic Hydrocephalus</title><author>Rajani H,</author><journal>J Clin Imaging Sci</journal><year>2018</year><book /><volume>8</volume><number>0</number><pages>20</pages><co_aut>et al.</co_aut></literature><literature><id>6479</id><title>Glutaric Aciduria Type 1 with Microcephaly: Masquerading as Spastic Cerebral Palsy</title><author>Sharawat IK,</author><journal>J Pediatr Neurosci</journal><year>2018</year><book /><volume>13</volume><number>3</number><pages>349-351</pages><co_aut>Dawman L</co_aut></literature><literature><id>6482</id><title>Quantitation of plasma and urine 3-hydroxyglutaric acid, after separation from 2-hydroxyglutaric acid and other compounds of si</title><author>Simon GA,</author><journal>J Chromatogr B Analyt Technol Biomed Life Sci</journal><year>2018</year><book /><volume>1097</volume><number>0</number><pages>101-110</pages><co_aut>Wierenga A</co_aut></literature><literature><id>6483</id><title>Malignant brain tumors in patients with glutaric aciduria type I</title><author>Serrano Russi A,</author><journal>Mol Genet Metab</journal><year>2018</year><book /><volume>125</volume><number>3</number><pages>276-280</pages><co_aut>et al.</co_aut></literature><literature><id>4002</id><title>Manifestation einer Glutarazidurie Typ I (GA-I) bei einem Kind mit falsch negativem Neugeborenen-Screening</title><author>Fingerhut R,</author><journal>31- Jahrestagung APS Fulda 2017</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>5719</id><title>Impairment of astrocytic glutaminolysis in glutaric aciduria type I</title><author>Komatsuzaki S,</author><journal>J Inherit Metab Dis</journal><year>2017</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>6103</id><title>Severe Acute Subdural Hemorrhages in a Patient with Glutaric Acidemia Type 1 under Recommended Treatment</title><author>Ishige M,</author><journal>Pediatr Neurosurg</journal><year>2017</year><book /><volume>52</volume><number>1</number><pages>46-50</pages><co_aut>et al.</co_aut></literature><literature><id>7438</id><title>Elevated glutaric acid levels in Dhtkd1-/Gcdh- double knockout mice challenge our current understanding of lysine metabolism</title><author>Biagosch C,</author><journal>Biochim Biophys Acta Mol Basis Dis</journal><year>2017</year><book /><volume>1863</volume><number>9</number><pages>2220-2228</pages><co_aut>et al.</co_aut></literature><literature><id>6101</id><title>Occurrence of subdural hematomas in Dutch glutaric aciduria type 1 patients</title><author>Vester ME,</author><journal>Eur J Pediatr</journal><year>2016</year><book /><volume>175</volume><number>7</number><pages>1001-1006</pages><co_aut>et al.</co_aut></literature><literature><id>3902</id><title>A role of astrocytes in mediating postnatal neurodegeneration in Glutaric acidemia-type 1</title><author>Olivera-Bravo S,</author><journal>FEBS Lett</journal><year>2015</year><book /><volume>589</volume><number>22</number><pages>3492-3497</pages><co_aut>Barbeito L</co_aut></literature><literature><id>3904</id><title>Glutaric Acidemia Type 1-Clinico-Molecular Profile and Novel Mutations in GCDH Gene in Indian Patients</title><author>Gupta N,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>21</volume><number>0</number><pages>45-55</pages><co_aut>et al.</co_aut></literature><literature><id>3985</id><title>Rare Late-Onset Presentation of Glutaric Aciduria Type I in a 16-Year-Old Woman with a Novel GCDH Mutation</title><author>Fraidakis MJ,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>18</volume><number>0</number><pages>85-92</pages><co_aut>et al.</co_aut></literature><literature><id>5159</id><title>Erratum to: Glutaric Acidemia Type 1-Clinico-Molecular Profile and Novel Mutations in GCDH Gene in Indian Patients</title><author>Gupta N,</author><journal>JIMD Rep</journal><year>2015</year><book /><volume>21</volume><number>0</number><pages>129</pages><co_aut>et al.</co_aut></literature><literature><id>6100</id><title>Severe Acute Subdural Hemorrhage in a Patient With Glutaric Aciduria Type I After Minor Head Trauma: A Case Report</title><author>Zielonka M,</author><journal>J Child Neurol</journal><year>2015</year><book /><volume>30</volume><number>8</number><pages>1065-1069</pages><co_aut>et al.</co_aut></literature><literature><id>3903</id><title>White matter injury induced by perinatal exposure to glutaric acid</title><author>Olivera-Bravo S,</author><journal>Neurotox Res</journal><year>2014</year><book /><volume>25</volume><number>4</number><pages>381-391</pages><co_aut>et al.</co_aut></literature><literature><id>3905</id><title>Increased blood-brain barrier permeability and alterations in perivascular astrocytes and pericytes induced by intracisternal glutaric acid</title><author>Isasi E,</author><journal>Fluids Barriers CNS</journal><year>2014</year><book /><volume>11</volume><number>0</number><pages>15</pages><co_aut>et al.</co_aut></literature><literature><id>3174</id><title>Ammonium Accumulation and Cell Death in a Rat 3D Brain Cell Model of Glutaric Aciduria Type I</title><author>Jafari P,</author><journal>PLoS One</journal><year>2013</year><book /><volume>8</volume><number>1</number><pages /><co_aut>et al.</co_aut></literature><literature><id>3127</id><title>Update on clinical aspects and treatment of selected vitamin-responsive disorders II (riboflavin and CoQ 10)</title><author>Horvath R</author><journal>J Inherit Metab Dis</journal><year>2012</year><book /><volume>35</volume><number>4</number><pages>679-687</pages><co_aut /></literature><literature><id>6104</id><title>Diagnosis and management of glutaric aciduria type I--revised recommendations</title><author>Koelker S,</author><journal>J Inherit Metab Dis</journal><year>2011</year><book /><volume>34</volume><number>3</number><pages>677-694</pages><co_aut>et al.</co_aut></literature><literature><id>4691</id><title>Two inborn errors of metabolism in a newborn: glutaric aciduria type I combined with isobutyrylglycinuria</title><author>Popek M,</author><journal>Clin Chim Acta</journal><year>2010</year><book /><volume>411</volume><number>23</number><pages>2087-2091</pages><co_aut>et al.</co_aut></literature><literature><id>2820</id><title>Glutaric aciduria type 1 presenting with epilepsy</title><author>McClelland VM,</author><journal>Dev Med Child Neurol</journal><year>2009</year><book /><volume>51</volume><number>3</number><pages>235-239</pages><co_aut>et al.</co_aut></literature><literature><id>2794</id><title>Maternal glutaric acidemia, type I identified by newborn screening</title><author>Crombez EA</author><journal>Mol Genet Metab</journal><year>2008</year><book /><volume>94</volume><number>1</number><pages>132-134</pages><co_aut>et al.</co_aut></literature><literature><id>2746</id><title>Decline of Acute Encephalopathic Crises in Children with Glutaryl-CoA Dehydrogenase Deficiency Identified by Newborn Screening </title><author>Koelker S</author><journal>Pediatr Res</journal><year>2007</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2372</id><title>Breastfeeding experience in inborn errors of metabolism other than phenylketonuria</title><author>Huner G</author><journal>J Inherit Metab Dis</journal><year>2005</year><book /><volume>28</volume><number>4</number><pages>457-465</pages><co_aut>et al.</co_aut></literature><literature><id>2552</id><title>Glutaric aciduria type I: a neuroimaging diagnosis?</title><author>Santos CC</author><journal>J Child Neurol</journal><year>2005</year><book /><volume>20</volume><number>7</number><pages>588-590</pages><co_aut>Roach ES</co_aut></literature><literature><id>2580</id><title>Glutaconyl-CoA is the main toxic agent in glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I)</title><author>Lehnert W</author><journal>Med Hypotheses</journal><year>2005</year><book /><volume>65</volume><number>2</number><pages>330-333</pages><co_aut>Sass JO</co_aut></literature><literature><id>2747</id><title>Late-onset neurologic disease in glutaryl-CoA dehydrogenase deficiency</title><author>Kuelkens S</author><journal>Neurology</journal><year>2005</year><book /><volume>64</volume><number>12</number><pages>2142-2144</pages><co_aut>et al.</co_aut></literature><literature><id>6233</id><title>The urinary excretion of glutarylcarnitine is an informative tool in the biochemical diagnosis of glutaric acidemia type I</title><author>Tortorelli S,</author><journal>Mol Genet Metab</journal><year>2005</year><book /><volume>84</volume><number>2</number><pages>137-143</pages><co_aut>et al.</co_aut></literature><literature><id>1876</id><title>Glutaric aciduria type I associated with learning disability</title><author>Patil N</author><journal>Indian J Pediatr</journal><year>2004</year><book /><volume>71</volume><number>10</number><pages>948</pages><co_aut>et al.</co_aut></literature><literature><id>1879</id><title>Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1</title><author>Kyllerman M</author><journal>Eur J Paediatr Neurol</journal><year>2004</year><book /><volume>8</volume><number>3</number><pages>121-129</pages><co_aut>et al.</co_aut></literature><literature><id>1880</id><title>Management of movement disorders in glutaryl-CoA dehydrogenase deficiency: anticholinergic drugs and botulinum toxin as additio</title><author>Burlina AP</author><journal>J Inherit Metab Dis</journal><year>2004</year><book /><volume>27</volume><number>6</number><pages>911-915</pages><co_aut>et al.</co_aut></literature><literature><id>939</id><title>Diagnosis and management of glutaric aciduria tye I</title><author>Baric I</author><journal>J Inherit Metab Dis</journal><year>1998</year><book /><volume>21</volume><number>4</number><pages>326-340</pages><co_aut>et al.</co_aut></literature><literature><id>978</id><title>A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism</title><author>Thomason MJ</author><journal>J Public Health Med</journal><year>1998</year><book /><volume>20</volume><number>3</number><pages>331-343</pages><co_aut>et al.</co_aut></literature><literature><id>773</id><title>Early clinical manifestation of glutaric aciduria type I and nephrotic syndrome during the first months of life</title><author>Poege AP</author><journal>Acta Paediatr</journal><year>1997</year><book /><volume>86</volume><number>0</number><pages>1144-1147</pages><co_aut>et al.</co_aut></literature><literature><id>732</id><title>Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency</title><author>Hoffmann GF</author><journal>Neuropediatrics</journal><year>1996</year><book /><volume>27</volume><number>0</number><pages>115-123</pages><co_aut>et al.</co_aut></literature><literature><id>168</id><title>Organic acidemias due to defects in lysine oxidation:2-ketoadipic acidemia and glutaric acidemia</title><author>Goodman SI</author><journal>The metabolic and molecular bases of inherited disease, 7/e; Editors: C.R.Scriver, A.L.Beaudet, W.S.Sly, D.Valle; McGraw-Hill Inc.</journal><year>1995</year><book /><volume>1</volume><number>42</number><pages>1451-1460</pages><co_aut>Frerman FE</co_aut></literature><literature><id>302</id><title>Early signs and course of disease of glutaryl-CoA dehydrogenase deficiency</title><author>Hoffmann GF</author><journal>J Inherit Metab Dis</journal><year>1995</year><book /><volume>18</volume><number>0</number><pages>173-176</pages><co_aut>et al.</co_aut></literature><literature><id>396</id><title>CT and MR of the brain in the diagnosis of organic acidemias. Experience from 107 patients</title><author>Brismar J</author><journal>Brain Dev Suppl</journal><year>1995</year><book /><volume>16</volume><number>0</number><pages>104-124</pages><co_aut>Ozand PT</co_aut></literature><literature><id>405</id><title>Variable clinical findings and biochemical presentation of seven spanish cases with glutaryl-CoA-dehydrogenase deficiency</title><author>Merinero B</author><journal>Neuropediatrics</journal><year>1995</year><book /><volume>26</volume><number>5</number><pages>238-242</pages><co_aut>et al.</co_aut></literature><literature><id>406</id><title>Glutaric aciduria: improved MR appearance after aggressive therapy</title><author>Cho CH</author><journal>Pediatr Radiol</journal><year>1995</year><book /><volume>25</volume><number>6</number><pages>484-485</pages><co_aut>et al.</co_aut></literature><literature><id>300</id><title>Dystonia and dyskinesia in glutaric aciduria type I: clinical heterogeneity and therapeutic considerations</title><author>Kyllerman M</author><journal>Mov Disord</journal><year>1994</year><book /><volume>9</volume><number>1</number><pages>22-30</pages><co_aut>et al.</co_aut></literature><literature><id>407</id><title>Two cases of glutaric aciduria type I: clinical and neuropathological findings</title><author>Kimura S</author><journal>J Neurol Sci</journal><year>1994</year><book /><volume>123</volume><number>0</number><pages>38-43</pages><co_aut>et al.</co_aut></literature><literature><id>301</id><title>Neuroradiological findings in glutaric aciduria type I: report of four japanese patients</title><author>Nagasawa H</author><journal>Acta Paediatr Jpn</journal><year>1992</year><book /><volume>34</volume><number>4</number><pages>409-415</pages><co_aut>et al.</co_aut></literature><literature><id>303</id><title>Glutaryl-Coenzyme A dehydrogenase deficieny: a distinct encephalopathy</title><author>Hoffmann GF</author><journal>Pediatrics</journal><year>1991</year><book /><volume>88</volume><number>0</number><pages>1194-1203</pages><co_aut>et al.</co_aut></literature><literature><id>304</id><title>Asymptomatische Makrocephalie als Fruehsymptom von Organoazidopathien</title><author>Hoffmann GF</author><journal>in Luetschg J (Hrsg.): Aktuelle Neuropaediatrie 1990</journal><year>1990</year><book /><volume>0</volume><number>0</number><pages>292-296</pages><co_aut>et al.</co_aut></literature><literature><id>305</id><title>Extrapyramidale Bewegungsstoerungen und Anarthrie als Erstmanifestation der Glutarazidaemie I</title><author>Weisser J</author><journal>in L&#180;+&#162;tschg J (Hrsg.): Aktuelle Neuropaediatrie 1990</journal><year>1990</year><book /><volume>0</volume><number>0</number><pages>361-365</pages><co_aut>Hoffmann GF, Lipinski CG, Trefz FK</co_aut></literature></Literatures></Disease>